Saxagliptin Hydrochloride Monohydrate is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor primarily indicated for the management of type 2 diabetes mellitus to help improve glycemic control. This class… Read more
Saxagliptin Hydrochloride Monohydrate is an oral dipeptidyl peptidase-4 (DPP-4) inhibitor primarily indicated for the management of type 2 diabetes mellitus to help improve glycemic control. This class of medication works by increasing the levels of incretin hormones, which regulate insulin and glucose production. To ensure the accuracy of analytical testing, method validation, and rigorous quality control protocols, researchers rely on high-quality reference materials. This category provides access to pharmaceutical reference standards of the active ingredient, as well as essential pharmacopeial and non-pharmacopeial impurities, metabolites, and stable isotope-labelled compounds. These materials facilitate precise impurity profiling and quantitative analysis throughout the drug development and manufacturing lifecycle, supporting the verification of purity and stability in pharmaceutical formulations of this DPP-4 inhibitor.